drugset / Trial / NCT04892251
Ketamine Assisted Psychotherapy for Opioid Use Disorder
RandomizedParallel-groupDouble-blindTreatment
Summary
This pilot clinical trial aims to assess the preliminary efficacy of ketamine as an adjunct for a mindfulness-based intervention for opioid use disorder.
Timeline
- Start
- 2021-05-20
- Primary completion
- 2023-12-30
- Completion
- 2024-05-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ketamine | Small molecule | 0.5 mg/kg | Intramuscular |
| Subject | Ketamine | Small molecule | 1.5 mg/kg | Intramuscular |